Imaging tests overused to diagnose pure breast pain among women.
Complaints of breast pain often result in overutilization of healthcare resources, according to a study published in the American Journal of Roentgenology.
Researchers from the University of Texas MD Anderson Cancer Center in Houston analyzed
the incidence of women with breast pain who presented to an imaging center, and assessed the imaging findings, outcomes, and workup costs. Patients who were pregnant or lactating, had a history of breast cancer, or presented with palpable nipple or skin findings were excluded.
A total of 799 patients participated in the study:
• 30 percent of the patients presented with diffuse pain
• 30 percent presented with focal pain
• 40 percent of pain was not localized
Almost all patients, 99 percent, presented for a diagnostic evaluation, but 759 (95 percent) of these evaluated patients had negative findings. One patient had a single cancer detected in the contralateral asymptomatic breast. Workup studies included ultrasound, mammography, MRI, and digital breast tomosynthesis.
When correlations between breast pain and the presence of cancer in the study patients were compared with the concurrent cancer detection rate in the screening population (5.5 cases per 1,000 examinations performed), breast pain was not found to be a sign of breast cancer. Women younger than 40 years (316 of 799 patients) underwent 454 workup studies at a total cost of $87,322, but no cancer was detected in this group. There were 745 imaging studies performed on the patients over 40 years (483 of 799 patients), at a cost of $152,732.
The researchers concluded that breast pain resulted in the overuse of healthcare resources. They suggested when women 40 years or older present with pure breast pain, breast imaging centers should consider recommending an annual screening mammogram and for women younger than 40, reassurance without imaging.
Mammography Study Suggests DBT-Based AI May Help Reduce Disparities with Breast Cancer Screening
December 13th 2024New research suggests that AI-powered assessment of digital breast tomosynthesis (DBT) for short-term breast cancer risk may help address racial disparities with detection and shortcomings of traditional mammography in women with dense breasts.
Mammography News: FDA Grants Expanded 510(k) Clearance for AI-Powered SmartMammo Dx DBT Software
November 29th 2024Originally cleared by the FDA in 2021, the SmartMammo Dx software for digital breast tomosynthesis (DBT) can now be utilized with the Senographe Pristina mammography systems from GE HealthCare.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.